Inventor

DULL GARY M

US33 patents

⚠️ This page may combine multiple inventors who share the name “DULL GARY M”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

DULL GARY M

REYNOLDS TOBACCO CO R

Nicotine salts, co-crystals, and salt co-crystal complexes

Tobacco processing

Electronic smoking article with improved storage of aerosol precursor compositions

Nicotine salts, co-crystals, and salt co-crystal complexes

Tobacco processing

Nicotine salts, co-crystals, and salt co-crystal complexes

Nicotine salts, co-crystals, and salt co-crystal complexes

Nicotine salts, co-crystals, and salt co-crystal complexes

Nicotine salts, co-crystals, and salt co-crystal complexes

Method of providing an aroma and flavor precursor for smoking articles

Nicotine salts, co-crystals, and salt co-crystal complexes

Nicotine salts, co-crystals, and salt co-crystal complexes

Nicotine salts, co-crystals, and salt co-crystal complexes

Nicotine salts, co-crystals, and salt co-crystal complexes

Nicotine salts, co-crystals, and salt co-crystal complexes

Aerosol delivery device including a segregated substrate

RAI STRATEGIC HOLDINGS INC

Electronic smoking article with improved storage of aerosol precursor compositions

Arrangement of atomization assemblies for aerosol delivery device

Method for hydrolysis of lactic acid for aerosol delivery device

Method for formulating aerosol precursor for aerosol delivery device

Electronic smoking article with improved storage of aerosol precursor compositions

Arrangement of atomization assemblies for aerosol delivery device

Electronic smoking article with improved storage of aerosol precursor compositions

(unassigned)

Pyrimidinyl or Pyridinyl alkenyl amine compounds

Pharmaceutical compositions for the treatment of central nervous system disorders

(3-(5-ethoxypyridin)yl)-alkenyl 1 amine compounds

Pharmaceutical compositions for prevention and treatment of ulcerative colitis

Compounds which are useful for prevention and treatment of central nervous system disorders

TARGACEPT INC

Pharmaceutical compositions and methods for use

Compounds capable of activating cholinergic receptors

Compounds capable of activating cholinergic receptors

ASTRAZENECA AB

Salt forms of (2S)-(4E)-N-methyl-5-[3-(5-isopropoxypyridin)y1]-4-penten 2-amine

DULL GARY M

Polymorph forms of (2S)-(4E)-N-methyl-5-[3-(5-isopropdxypyridin)yl]-4-penten-2-amine